Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
687
datasets available to search
ShareScore release 0.9.0
Dataset results
687 results for “MDS”
5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT01038635. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) P
ClinicalTrials.gov study NCT03682536. IPD Sharing: Not stated. Countries: 26. Publications: 4.
Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients with Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03150004. IPD Sharing: NO. Countries: 1. Publications: 2.
Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation
ClinicalTrials.gov study NCT02719574. IPD Sharing: Not stated. Countries: 9. Publications: 5.
A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS
ClinicalTrials.gov study NCT02488408. IPD Sharing: YES. Countries: 4. Publications: 16.
Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02464657. IPD Sharing: Not stated. Countries: 1. Publications: 1.
LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00691938. IPD Sharing: Not stated. Countries: 1. Publications: 1.
AZD6738 for Patients With Progressive MDS or CMML
ClinicalTrials.gov study NCT03770429. IPD Sharing: YES. Countries: 1. Publications: 0.
Low Dose Melphalan and Bortezomib for AML and High-Risk MDS
ClinicalTrials.gov study NCT00789256. IPD Sharing: Not stated. Countries: 1. Publications: 20.
APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT03931291. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hetrombopag for Low/Intermediate-1 Risk MDS With Thrombocytopenia
ClinicalTrials.gov study NCT05024877. IPD Sharing: YES. Countries: 1. Publications: 1.
Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003
ClinicalTrials.gov study NCT01099267. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03614728. IPD Sharing: YES. Countries: 2. Publications: 1.
Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02598661. IPD Sharing: NO. Countries: 17. Publications: 3.
Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality
ClinicalTrials.gov study NCT00065156. IPD Sharing: Not stated. Countries: 2. Publications: 4.
Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS
ClinicalTrials.gov study NCT03660228. IPD Sharing: NO. Countries: 1. Publications: 1.
Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01362140. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102)
ClinicalTrials.gov study NCT02016781. IPD Sharing: YES. Countries: 1. Publications: 5.
An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patient
ClinicalTrials.gov study NCT02775903. IPD Sharing: Not stated. Countries: 12. Publications: 4.
Genetic barcoding systematically comparing haploinsufficiency of key genes in del(5q) MDS reveals a central role for CSNK1A1 in clonal expansion
<p>R object with pre-processed single cell data of the manuscript "<strong>Genetic barcoding systematically comparing haploinsufficiency of key genes in del(5q) MDS reveals a central role for </strong><em>CSNK1A1</em><strong> in clonal expansion"</strong></p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.